section name header

Evidence summaries

Corticosteroids for Preventing Postherpetic Neuralgia

Corticosteroids may not be effective in preventing postherpetic neuralgia. Level of evidence: "C"

A Cochrane review [Abstract] 1 included 5 studies with a total of 787 subjects. There was no significant difference between the corticosteroid and control groups for the primary outcome, the presence of postherpetic neuralgia six months after the onset of the acute herpetic rash (RR 1.27, 95% CI 0.20 to 7.97). There was also no significant difference between the corticosteroid plus antiviral agents and placebo plus antiviral agents groups for the primary outcome (RR 0.90, 95% CI 0.40 to 2.03). A meta-analysis of two trials (n=114) showed that oral corticosteroids did not prevent postherpetic neuralgia 6 months after the herpes onset (RR 0.95; 95% CI 0.45 to 1.99). There was no significant difference in any adverse events.

Comment: The quality of evidence is downgraded by imprecise results (limited study size for each comparison) and by indirectness (differences in studied interventions, wide time range of the included studies).

    References

    • Han Y, Zhang J, Chen N et al. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2013;3():CD005582. [PubMed]

Primary/Secondary Keywords